Improve oculomotor control in Parkinsons
- Trial ID
- NCT06032130
- Official Title
- "Characterization of Visual Problems in Patients With Parkinson's Disease and Application of an Oculomotor and/or Perceptual Therapy Program"
- Goal
- Improve oculomotor control in Parkinsons
- Status
- RECRUITING
- Sponsor
- University of Valencia
- Study Type
- OBSERVATIONAL
- Enrollment
- 160 participants
- Conditions
- Parkinson Disease
- Interventions
- Clinical measurements, Oculomotor or perceptual therapy
Plain-Language Summary
The goal is to map the specific visual and eye-movement problems people with Parkinson's have, and to see if targeted oculomotor and perceptual therapy can improve functions like tracking, saccades, fixation and visual processing that affect reading, spatial awareness and daily tasks. Participants undergo detailed clinical eye measurements and some take part in a behavioral therapy program that trains eye movements and visual attention,things like saccade and smooth‑pursuit exercises and perception tasks,so it is nonpharmacologic and does not interact with levodopa. The study is looking for adults aged 30 to 100 with a Parkinson's diagnosis who can complete the tests, excluding anyone with other eye diseases, major systemic or neurological illnesses, or medications that impair vision, and it also enrolls age- and sex-matched healthy controls.
Locations
- Hospital Arnau de Vilanova, Valencia, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Clinical measurements. The goal is to map the specific visual and eye-movement problems people with Parkinson's have, and to see if targeted oculomotor and perceptual therapy can improve functions like tracking, saccades, fixation and visual processing that affect reading, spatial awareness and daily tasks. Participants undergo detailed clinical eye measurements and some take part in a behavioral therapy program that trains eye movements and visual attention,things like saccade and smooth‑pursuit exercises and perception tasks,so it is nonpharmacologic and does not interact with levodopa. The study is looking for adults aged 30 to 100 with a Parkinson's diagnosis who can complete the tests, excluding anyone with other eye diseases, major systemic or neurological illnesses, or medications that impair vision, and it also enrolls age- and sex-matched healthy controls.
- Who can participate?
- Participants must be between 30 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 8 months.